biointron_4

Biointron invites you to join us at BIO KOREA 2024! Bio Krea has been a premier international convention for biotech companies and industry leaders. Scheduled from May 8th to 10th, 2024, at COEX in Seoul, this event promises to be a nexus of innovation in the health industry.

Biointron is excited to invite you to Biologics 2024, scheduled from 13th to 15th March in London, UK. This event, Europe's leading platform for biologics discovery and development, promises to be a pivotal gathering for industry experts and thought leaders.

The Antibody Therapeutics Xchange 2024, set to take place in San Diego on February 26th, is a highly anticipated event in the world of antibody therapeutics, and Biointron is proud to be a part of it.

Biointron has developed our own CHOK1-Fut8KO expression platform for afucosylated antibodies.

Biointron established a single-B cell antibody discovery platform based on microfluidic technology. Combined with our proprietary fast antibody expression platform, it has been proven to be fast and efficient in many projects.

Biointron has developed a successful method for discovering alpaca VHH for over 200 projects, using flexible immunization strategies and a robust phage display screening platform.

The Biointron team is excited to announce our participation in the Festival of Biologics 2024.

Biointron is excited to announce our participation in the upcoming AACR (American Association for Cancer Research) 2024 Annual Meeting.

Biointron is thrilled to announce our participation in the upcoming 23rd Annual PepTalk conference, scheduled for January 16-19 in San Diego.

Research into treatments for Alzheimer's disease (AD) has reached impressive milestones this year.

The last few decades have witnessed an acceleration in the discovery and development of therapeutic antibodies.

Respiratory syncytial virus (RSV) has recently gained much attention due to the approval of several drugs this year.On May 3, 2023, the U.S. Food and Drug Administration (FDA) authorized Arexvy, the first RSV vaccine for use in the United States.

Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.